Medication info
Neuraren Tablet (Choline Alphoscerate)

Neuraren Tablet (Choline Alphoscerate)

Prescription medicationTabletOral
Ingredient · strength
Choline Alfoscerate›400mg / 1 tablet
Manufacturer / importer
Myungmoon Pharmaceutical Co., Ltd.
Appearance
Pale yellow round film-coated tablet
Packaging
Domestic use - 90 tablets/PTP [(10 tablets/PTP x 9)]
Approval status
Active

MFDS item code 201402987 · Approved 2014.07.07 · Insurance code 649806600

Summary

Main use
Improvement of symptoms of cerebrovascular deficits and organic brain syndrome (e.g., memory impairment and confusion)
Who takes it
Adults
Adult dose
Administer 400 mg of choline alfoscerate per dose orally 2~3 times daily. Adjust the dose as appropriate according to symptoms.

Ingredients

Manufacturer
Myungmoon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of symptoms of cerebrovascular deficits and organic brain syndrome (e.g., memory impairment and confusion)

  • Memory impairment
  • confusion
  • disorientation
  • lack of motivation and spontaneity
  • decreased concentration
View approved original text

This medication is effective for secondary symptoms caused by cerebrovascular deficits and memory impairment, confusion, lack of motivation and spontaneity, disorientation, and decreased concentration caused by degenerative brain diseases. It helps to stabilize the mental functions of patients by improving these symptoms. Its safety and efficacy have been demonstrated through clinical trials in South Korea, making it a reliable option. Therefore, it is used to relieve symptoms related to memory and cognitive decline.

How to take

Adult dose

Administer 400 mg of choline alfoscerate per dose orally 2~3 times daily. Adjust the dose as appropriate according to symptoms.

Precautions

This medication should not be used by patients who have had allergic reactions to this drug or its components. Pregnant women or women who may become pregnant should not take this medication. Nausea may occur while taking this medication, which could be due to the action of the neurotransmitter dopamine in the brain. If such symptoms arise, it is recommended to consult a physician to reduce the dosage of the medication. Additionally, it may affect the digestive system and can lead to gastritis or gastrointestinal disorders. It may affect the central nervous system, causing drowsiness, insomnia, irritability, or nervousness, and in rare cases may lead to seizures or hyperactivity. This medication should be kept in a safe place out of the reach of children. Transferring the medication from its original packaging to another container can negatively affect the quality of the medication and may cause accidents, so caution is advised.

Side effects

nausea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, preferably at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness over a longer period.

Appearance and packaging

Appearance

Pale yellow round film-coated tablet

Package unit

Domestic use - 90 tablets/PTP [(10 tablets/PTP x 9)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.